title: [The effect of obzidan monotherapy on the beta 2-adrenoreceptors of the lymphocyte adenylate cyclase system in hypertension patients].
abstract: Obsidan (propranolol) monotherapy was investigated for the effect on the density of lymphocytic beta2-adrenoreceptors (B max), the activity of lymphocytic homogenates adenylate cyclase (AC), plasma renin activity (PRA), aldosterone concentration (A) and plasma catecholamines (CA). Obsidan treatment brought about a 40% increase in B max without a significant changes in AC activity. Contrary to a significant fall in PRA, A and norepinephrine in plasma reduced insignificantly. Changes in B max correlated with its baseline level (r = -0.56, p < 0.01), PRA (r = 0.57, p < 0.01) and A level in plasma (r = 0.62, p < 0.01). No significant correlations appeared between hypotensive effect of the drug and drug-related changes in B max and AC activity, while PRA and A concentrations showed such dependence. B max and before treatment mass of the left ventricular myocardium correlated significantly (r = = 0.595, p < 0.01). A small decrease in the myocardial mass followed obsidan administration, being related to B max (r = = 0.497, p < 0.05). It is concluded that obsidan-induced changes in lymphocytic beta 2-adrenoreceptors correlate with alterations in the activity of renin-angiotensin-aldosterone system and myocardial hypertrophy dynamics.
authors.forename: E V
authors.initials: EV
authors.lastname: Parfenova
authors.forename: T L
authors.initials: TL
authors.lastname: Krasnikova
authors.forename: N A
authors.initials: NA
authors.lastname: Aripova
authors.forename: E
authors.initials: E
authors.lastname: Nauman
authors.forename: E G
authors.initials: EG
authors.lastname: D'iakonova
authors.forename: V P
authors.initials: VP
authors.lastname: Masenko
authors.forename: A V
authors.initials: AV
authors.lastname: Mazaev
mesh_terms: D000262:Adenylyl Cyclases / Q000097:blood / Q000187:drug effects*; D000328:Adult; D004341:Drug Evaluation; D006352:Heart Ventricles / Q000187:drug effects; D006801:Humans; D006973:Hypertension / Q000097:blood / Q000188:drug therapy*; D008214:Lymphocytes / Q000187:drug effects* / Q000201:enzymology; D008297:Male; D008875:Middle Aged; D018377:Neurotransmitter Agents / Q000097:blood; D009929:Organ Size / Q000187:drug effects; D011433:Propranolol / Q000494:pharmacology / Q000627:therapeutic use*; D011943:Receptors, Adrenergic, beta / Q000187:drug effects* / Q000378:metabolism
chemical_list: D018377:Neurotransmitter Agents; D011943:Receptors, Adrenergic, beta; D011433:Propranolol; D000262:Adenylyl Cyclases
vernacular_title: Vliianie monoterapii obzidanom na beta 2-adrenoretseptornuiu adenilattsiklaznuiu sistemu limfotsitov bol'nykh gipertonicheskoĭ bolezn'iu.